Prescription medicine

Indium in 111 pentetate

Indium in 111 pentetate is a prescription medicine with an FDA approval on record since 1982. No generic is listed in FDA's NDC Directory.

No generic listed

Check it at the source: the indium in 111 pentetate FDA label on DailyMed (effective January 10, 2024, Medi-Physics, Inc. dba GE Healthcare); the NDA 17707 record on Drugs@FDA; every indium in 111 pentetate label on DailyMed.

Highlights of the record

FDA label of January 10, 2024; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage
Pentetate Indium Disodium In 111 is recommended for use in radionuclide cisternography.

Forms and strengths

Solution.

On the market

Earliest approval on file: February 18, 1982 Mpi Indium Dtpa In 111, Ge Healthcare; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals: No generic approved
Labelers listed (NDC): 1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC): Not in the survey
Shortage (FDA): No current entry
Recalls by its makers (FDA): No recall recorded
FAERS reports: 14 through July 30, 2026

What is indium in 111 pentetate used for?

From the label: indications and usage
Pentetate Indium Disodium In 111 is recommended for use in radionuclide cisternography.

FDA pharmacologic class: Radioactive Diagnostic Agent.

Source: FDA drug label (Indium DTPA In 111), Medi-Physics, Inc. dba GE Healthcare, effective January 10, 2024 (SPL set 4fea5871-b515-4f69-a297-11507ddd7817), via openFDA; the full label on DailyMed

Is there a generic for indium in 111 pentetate?

No generic indium in 111 pentetate is approved (Drugs@FDA, October 8, 2026).

1982 earliest approval on file

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What do FAERS reports show for indium in 111 pentetate?

The FDA Adverse Event Reporting System holds 14 reports that list indium in 111 pentetate among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 0 are coded as a death and 0 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

No Adverse Event (a use or a product term, not a reaction)13
Drug Ineffective (a use or a product term, not a reaction)8
Radioisotope Scan Abnormal3
False Positive Investigation Result2
Meningitis (named in the label)1

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Other radioactive diagnostic agents: the pharmacologic class, with prices and generics
Indium in 111 pentetate side effects: the label's list beside FAERS reports
Check an interaction: what two or more labels say about each other